Primary Menu
Skip to content
Lycera
About Us
Corporate Overview
Management Team
Board of Directors
Expanded Access
Programs
LYC-55716
ATPase Modulators
New IO Targets
Pipeline
Investors
Investors
Investor FAQ’s
Contact Us
News & Events
Press Releases
Lycera in the News
Careers
Contact Us
Lycera in the News
Agonizing Cancer Immunotherapy
Feb 23, 2015
BioCentury
Endogenous agonists for orphan RORγ
Jan 23, 2015
Nature Immunology Reviews
Lycera Enters Into Second Collaboration Deal with Merck
Mar 7, 2013
Xconomy
Merck ups autoimmune prize to $600M for small Michigan biotech
Mar 7, 2013
FierceBiotech
Lycera snags $307M anti-inflammatory discovery Deal with Merck
Mar 3, 2011
FierceBiotech
Targeting T cell metabolism
Mar 3, 2011
SciBx
Lycera Plows Ahead With Drugs To Treat Autoimmune Disorders
Feb 24, 2011
Xconomy
paging-navigation